Kelly Arnold is an Associate Professor in the Department of Biomedical Engineering at the University of Michigan. Her research integrates systems engineering principles with immunology to investigate variability in immune responses across infection, vaccination, and injury, with a focus on computational modeling and clinical translation. Research Focus Systems-level immune response modeling Vaccination and antibody functionality Vaginal microbiome-host interactions Chronic lung disease progression Computational serology and proteomics Recent Work Her 2025 studies examine SARS-CoV-2 vaccination responses in cancer patients and computational frameworks for vaginal probiotics. Earlier works (2024-2007) span COPD progression, lupus fibrosis, HIV susceptibility, and tissue engineering for fertility preservation. Methodologies include proteomic profiling, network modeling, and microfluidic systems.
Dr. Yunjie Yang is an Associate Professor at the University of Edinburgh's School of Engineering, with affiliations at the Edinburgh Futures Institute (EFI), the Edinburgh Generative AI Laboratory (GAIL), and the Edinburgh Centre for Robotics. He previously held the Chancellor's Fellow in Data Driven Innovation (2018-2023) and Bayes Innovation Fellow (2023-2024) positions. His research focuses on AI-powered sensing and imaging, machine learning, and soft sensors & electronics for robotics. Yang received his PhD in Engineering Electronics from the University of Edinburgh, MSc in Control Science & Engineering from Tsinghua University, and BEng in Measurement & Control Engineering from Anhui University. After his PhD, he worked as a Postdoctoral Research Associate in Chemical Species Tomography before securing his lectureship. His research interests center on developing intelligent sensing systems that replicate human perception capabilities for robotics and intelligent systems. He pioneers flexible sensing and imaging technologies across various scales through innovative multi-modal sensors, soft electronics, and their modeling using machine learning approaches. His work aims to enable autonomous physical artificial intelligence by bridging the gap between robotic systems and human-like perception. Analysis of his recent publications reveals a strong focus on soft robotics perception, particularly through electrical impedance tomography (EIT) and transformer-based architectures. His research spans medical imaging applications, digital twin modeling for industrial processes, and machine learning approaches for sensor data interpretation. The trend shows increasing integration of physics-informed deep learning with traditional tomographic techniques to achieve higher accuracy and efficiency. European Research Council (ERC) Starting Grant (2024) IEEE J. Barry Oakes Advancement Award (2024) IEEE I&M Society Graduate Fellowship Award (2015) Multiple Best Paper Awards Senior Member of IEEE Fellow of the International Society for Industrial Process Tomography Fellow of the Higher Education Academy ESI highly cited papers Dr. Yang serves as Associate Editor for IEEE Transactions on Instrumentation and Measurement and holds editorial positions with Scientific Reports and IEEE Sensors Journal. His research has been licensed to overseas research institutes and industry partners and received wide media coverage including BBC, EFE, USA Today, and STV. He has secured significant grant funding including the prestigious ERC Starting Grant. He leads the Edinburgh SMART Lab (Sensing/imaging + Machine Learning + Robotics), which aims to replicate human perception capabilities for robotics and advance flexible sensing technologies through innovative multi-modal sensors and machine learning approaches. The lab focuses on enabling autonomous physical artificial intelligence with applications spanning medical diagnostics, industrial monitoring, and advanced robotics systems.
Professor Robert McLaughlin is a faculty member in the School of Biomedicine at the University of Adelaide, affiliated with the Faculty of Health and Medical Sciences. He leads the Bioengineering Imaging Group and serves as Managing Director of the start-up Miniprobes. His research focuses on developing optical imaging technologies, including non-invasive tools for blood flow assessment and miniaturized imaging probes. He has secured over $14M in research grants and holds an h-index of 45 with 98 journal papers, 7 patents, and 2 book chapters. Prof. McLaughlin’s career includes roles at the University of Oxford and Siemens Medical Solutions, followed by academic leadership since 2007. His innovations span optical coherence tomography (OCT), fluorescence imaging, and dual-modality systems for clinical applications. Awards include the 2014 WA Innovator of the Year, 2015 Australian Innovation Challenge, and 2016 South Australian Premier’s Research Fellowship. His research emphasizes practical medical solutions, such as imaging needles for deep-tissue diagnostics and optical devices for real-time surgical monitoring. The Bioengineering Imaging Group collaborates with industry and academia to translate technologies into clinical practice.
Montserrat Anguera, Ph.D. is an Associate Professor in the Department of Biomedical Sciences at the University of Pennsylvania's School of Veterinary Medicine. Her research focuses on epigenetic mechanisms of gene regulation underlying sex differences in development and disease, with particular emphasis on X-chromosome inactivation (XCI) and its implications for female-biased autoimmune disorders. Dr. Anguera investigates how gene expression from the X-chromosome is regulated to ensure dosage compensation between males and females, and how these mechanisms become altered in diseases exhibiting sex-bias. Her laboratory has established novel epigenetic pathways involving the X-chromosome that impact human development, immune responses, and lymphocyte function. She employs advanced techniques including RNA/DNA fluorescence in situ hybridization, immunofluorescence, and allele-specific RNA sequencing to achieve single-cell resolution of epigenetic characteristics of the inactive X chromosome. Her research reveals a consistent focus on the intersection of X-chromosome biology and immunology, particularly regarding sex-biased autoimmune diseases like systemic lupus erythematosus. Key findings include the discovery that lymphocytes maintain X-chromosome inactivation differently than other somatic cells, with the inactive X exhibiting euchromatic features in female lymphocytes that may underlie female bias in autoimmune disorders. She coined the term 'dynamic XCI maintenance' to describe how T and B cells relocalize Xist RNA and heterochromatic marks to the inactive X chromosome following antigen-mediated stimulation. Dr. Anguera's laboratory includes postdocs Katherine Forsyth and Nikhil Jiwrajka, research specialist Zowie Searcy, graduate students Isabel Sierra and Natalie Toothacre, postdoctoral researcher Nuriban Valero-Pacheco, and PhD student Emma Welter. Together, they investigate epigenetic regulation of X-linked genes in development and disease contexts. She is an active member of multiple prestigious research institutes at Penn, including the Epigenetics Institute, Institute for Immunology, Center for Research on Reproduction & Women's Health, and Institute for Regenerative Medicine. Her work bridges epigenetics, immunology, and developmental biology, providing novel insights into mechanisms underlying female-biased autoimmune disorders.
Professor Hanadi Sleiman is a renowned academic in the Department of Chemistry at McGill University, specializing in DNA-based nanomaterials and their applications in drug delivery and supramolecular chemistry. She holds leadership roles, including Director of the NSERC CREATE training program in Nucleic Acids and President of the International DNA Nanotechnology Society (ISNSCE). Her research focuses on engineering DNA nanostructures for targeted therapies, such as cancer treatments, and advancing materials chemistry through DNA-functionalized systems. Education: Ph.D. in Chemistry, Stanford University (1990) Postdoctoral Fellow, University of Louis Pasteur (1993) Research Interests: Professor Sleiman’s work combines synthetic chemistry with DNA self-assembly to create programmable materials. Her lab designs DNA cages for drug encapsulation, explores DNA-minimal approaches to scalable materials, and integrates DNA with nanoparticles, polymers, and metals for biomedical applications. Key areas include cancer therapy, biosensors, and enzyme mimics. Awards & Honors: Fellow of the Royal Society of Canada (2017) Killam Research Fellowship (2018) R. U. Lemieux Award in Organic Chemistry (2018) William Dawson Scholar Award (2004–2012) Grants & Collaborations: She directs the NSERC CREATE program and collaborates with institutions like the Quebec Centre for Advanced Materials (QCAM) and the McGill Centre for Structural Biology (CRBS). Her training initiatives emphasize nucleic acid therapeutics and diagnostics. Labs & Teams: Her Sleiman Group at McGill develops innovative DNA architectures in the Otto Maass laboratory, with a focus on translational research for clinical applications.
Dr. Joshua Brinkerhoff is an Associate Professor in Mechanical Engineering at the University of British Columbia Okanagan Campus. He serves as the Associate Director for Research & Industrial Partnerships in the School of Engineering and leads the UBC-Okanagan Computational Fluid Dynamics Laboratory. His research spans computational fluid dynamics, turbomachinery, multiphase flows, hydrogen safety, wind energy, and biofluid mechanics. He teaches courses in mechanics of materials, alternative energy systems, turbulence, computational fluid dynamics, and aircraft design. PhD, Aerospace Engineering (Carleton University, Ottawa, ON) BEng, Aerospace Engineering (Carleton University) Dr. Brinkerhoff’s research interests include: Computational Fluid Dynamics (CFD) for laminar-to-turbulent transition and instability analysis Wind energy systems and turbine aerodynamics Hydrogen storage and safety protocols for transportation Biofluid mechanics for respiratory diseases and aneurysm modeling Multiphase flows in industrial and environmental contexts His publications focus on CFD simulations for: Aerosol dispersion and mitigation in indoor environments Wind farm interactions and atmospheric gravity waves Cavitation and phase transitions in cryogenic and LNG systems Heat transfer optimization in industrial and thermal systems Instability dynamics in buoyancy-driven and swept flows Turbulent structures in fluidized beds and reactors Dr. Brinkerhoff has no listed scientific awards in the provided data but has extensive contributions to renewable energy, hydrogen safety, and medical fluid dynamics. His laboratory develops open-source tools like TOSCA for large-eddy simulations and investigates practical applications in urban air quality, dental aerosol control, and turbine wake modeling.
Karthik Menon serves as an Assistant Professor with a joint appointment in the Woodruff School at Georgia Institute of Technology and the Coulter Department of Biomedical Engineering. His research integrates fluid mechanics, computational modeling, and data-driven methodologies to address critical challenges in healthcare, renewable energy, and bio-inspired engineering systems. His academic credentials include: Ph.D. in Mechanical Engineering, Johns Hopkins University (2021) M.S. in Mechanical Engineering, Johns Hopkins University (2019) B.E. in Mechanical Engineering, Birla Institute of Technology and Science, Pilani, India (2015) Menon's research program centers on three interconnected domains: cardiovascular flows for personalized treatment of heart disease, fluid-structure interactions in biological systems like heart valves and bio-mimetic robots, and vortex-dominated flows for renewable energy applications. His approach combines high-fidelity computational modeling with machine learning to uncover fundamental physics and develop clinical solutions, such as cardiovascular digital twins for non-invasive risk assessment. Current projects focus on patient-specific hemodynamics using CT imaging and uncertainty quantification to improve surgical planning. Analysis of his 15 most recent publications (2023-2025) reveals a dominant focus on advancing multi-fidelity computational frameworks for cardiovascular applications. Key trends include Bayesian uncertainty quantification, zero-dimensional solver development, and integration of clinical imaging data to create predictive digital twins. His work bridges fluid dynamics with clinical cardiology, targeting improved outcomes in coronary artery disease and Kawasaki-related complications through physics-informed machine learning. Menon's scholarly contributions have been recognized through competitive awards: WCCM-PANACM 2024 Travel Award, U.S. Association for Computational Mechanics (2024) Future Faculty Symposium Travel Award, Society of Engineering Science Conference (2023) Mark O. Robbins Prize in High-performance Computing, Johns Hopkins University (2021) Corrsin-Kovasznay Outstanding Paper Award, Johns Hopkins University (2020) Prosperetti Travel Award, Johns Hopkins University (2017) Mechanical Engineering Departmental Fellowship, Johns Hopkins University (2016) As principal investigator of the ComBiNE Fluid Dynamics Lab, Menon mentors graduate students in developing computational tools for fluid-structure interaction problems. His collaborative projects with cardiologists at Stanford and Emory hospitals translate engineering principles into clinical applications for cardiovascular disease management. Current grant activities focus on NSF and NIH-funded initiatives for uncertainty-aware cardiovascular modeling and bio-inspired flow energy harvesting. The ComBiNE Fluid Dynamics Lab operates as an interdisciplinary hub where engineers, clinicians, and data scientists collaborate on fluid mechanics challenges. Current lab initiatives include developing real-time hemodynamic simulators for surgical planning, creating reduced-order models for cardiac device optimization, and investigating vortex dynamics in fish schooling for underwater vehicle design. The lab maintains strong partnerships with Children's Healthcare of Atlanta and the Parker H. Petit Institute for Bioengineering and Bioscience.
Dr. James W. Navalta is an Associate Professor in the Department of Kinesiology and Nutrition Sciences at the University of Nevada, Las Vegas. His research focuses on physiological responses to outdoor exercise (hiking, trail running) and the validity/reliability of wearable technology. He earned his B.S. in Physical Education and Biology from Brigham Young University–Hawaii, M.S. in Kinesiology from UNLV, and Ph.D. in Exercise Physiology from Purdue University. Education: B.S. - Physical Education & Biology, Brigham Young University–Hawaii M.S. - Kinesiology, University of Nevada, Las Vegas Ph.D. - Exercise Physiology, Purdue University His research portfolio includes: Wearable technology validation for physiological measurements Comparative studies of indoor vs outdoor exercise environments Impact of gender-inclusive approaches on sports science Metabolic and cardiovascular responses to unconventional workouts Psychological benefits of nature immersion Recent publications demonstrate expertise in: Wearable device accuracy testing VO2max and lactate threshold validation Environmental influence on exercise physiology Methodological improvements in data collection Gender-inclusive research design Outdoor activity impact assessment As co-founder and executive editor of the International Journal of Exercise Science, he contributes significantly to academic discourse. He also serves on editorial boards for journals related to digital health and exercise technology.
Owen Skinner is an Assistant Professor in the Department of Chemistry and Chemical Biology at Northeastern University, affiliated with the Barnett Institute of Chemical and Biological Analysis. He leads the Skinner Lab, which specializes in high-resolution mass spectrometry to study protein-metabolite interactions in health and disease. Skinner earned his Ph.D. from Northwestern University and conducted postdoctoral research at Massachusetts General Hospital. His research focuses on thiol redox regulation, vitamin cofactor metabolism, and oxidative phosphorylation dynamics. Education: Ph.D. in Chemistry (Northwestern University), Postdoctoral Fellowship in Analytical Chemistry (Massachusetts General Hospital). Research interests include proteomics, metabolomics, mitochondrial dysfunction, and metabolic signaling. The lab actively recruits graduate students, undergraduates, and postdoctoral researchers across Northeastern's scientific community. Affiliations: Barnett Institute, College of Science Lab Members: PhD students Yifan Liu, Michael Xiao, Angela Rojas-Merchan; Undergraduates Helena Rittenhouse, Ridha Shah; High School collaborator Helen Loango Techniques: Native mass spectrometry, proteomics, metabolomics, redox biology Publications span mitochondrial metabolism, metabolic biomarkers in septic shock, and enzyme engineering. The lab emphasizes interdisciplinary collaboration and supports students through Northeastern's experiential learning programs.
Tao Huan is an Associate Professor in the Department of Chemistry , University of British Columbia , and holds the Canada Research Chair in Metabolomics and Exposomics . His research focuses on advancing mass spectrometry (MS) for metabolomics , integrating bioinformatics to address challenges in cancer metabolism , disease biomarker discovery , and exposome characterization . Education: Ph.D. in Analytical Chemistry (University of Alberta, 2015), Postdoctoral Research Associate (The Scripps Research Institute, 2015-2018). Dr. Huan’s work emphasizes systems biology , combining metabolomics with genomics and proteomics to decode complex biological mechanisms. He has pioneered methods for chemical isotope labeling and multimodal data integration , enhancing metabolite identification and pathway analysis. His recent publications (2020-2019) highlight innovations in LC-MS/MS workflows , freeze-thaw sample stability , and applications in colorectal cancer and Alzheimer’s disease . Dr. Huan’s lab actively recruits students and postdocs in analytical chemistry, metabolomics, and bioinformatics. Awards: Fred Beamish Award (2025), President’s Award, Metabolomics Society (2025), UBC Killam Faculty Research Award (2024), Michael Smith Health Research BC Scholar Award (2023). He serves as a faculty member in UBC’s Graduate Program in Bioinformatics , Genome Science and Technology , and the Cluster for Microplastics, Health and Environment . Lab alumni include Ph.D. and M.Sc. students now in academia and industry.
Dr. Ulas Bagci is an Associate Professor at Northwestern University's Feinberg School of Medicine, Department of Radiology. He holds courtesy appointments in Biomedical Engineering (BME), Electrical and Computer Engineering (ECE) at Northwestern, and Computer Science at the University of Central Florida. As the director of the Machine and Hybrid Intelligence Lab, his research focuses on AI and machine learning applications in biomedical and clinical imaging. Education: BS: Bilkent University (2003) MS: Koç University (2005) Fellow: University of Pennsylvania (2009) PhD: University of Nottingham (2010) ISTP Fellow: NIH (2012) Research Interests: Dr. Bagci’s work spans artificial intelligence, machine learning, and their integration into medical imaging workflows. His lab develops algorithms for tumor segmentation, radiomics analysis, and ethical AI frameworks in healthcare. Notable projects include large-scale MRI segmentation of cirrhotic livers and predictive models for clinical outcomes in oncology and cardiology. Publications: His recent work emphasizes AI-driven solutions for challenges in radiology, including lung disease detection, pulmonary embolism mortality prediction, and ethical considerations in foundational AI models. His articles reflect a focus on bridging clinical needs with advanced computational methods. Lab & Affiliations: The Machine and Hybrid Intelligence Lab collaborates with the Robert H. Lurie Comprehensive Cancer Center. Research themes include federated learning, medical image synthesis, and AI ethics in clinical decision-making.
Hugues Aschard is a Principal Investigator and Structure Manager at the Pasteur Institute in Paris, where he leads research in statistical genetics, microbiome analysis, and computational genomics. He is the principal investigator of the MicMat project, the EpiGenCOV Consortium, and several bioinformatics software initiatives including JASS, RAISS, and MGMM. Research Interests: Statistical and computational methods in genetics Genome-wide association studies (GWAS) Gene-environment interactions Microbiome and host genetics in inflammatory bowel disease Genetic epidemiology of infectious diseases like COVID-19 Development of open-source tools for multi-trait and summary-statistic analysis Recent Research Trends: His recent publications and projects emphasize integrative genetic modeling, multi-trait analysis across diverse populations, and the development of novel computational methods to handle missing data and improve SNP discovery. His work bridges statistical innovation with biological and clinical applications in complex diseases. Scientific Contributions: Development of JASS, RAISS, and MGMM software tools Leadership in large-scale consortia like EpiGenCOV Advancing methods for cross-ancestry genetic studies Advising and Collaboration: He supervises multiple PhD students and postdoctoral fellows, including Christophe Boetto, Antoine Auvergne, and Lucas Chataigner. He collaborates with major institutions such as APHP and CNRGH. His team includes research engineers and administrative staff, indicating an active and well-supported research group. Laboratories and Teams: He is a key member of the Biomaterials and Microfluidics team at the Pasteur Institute, where he contributes to interdisciplinary research involving Bayesian decision processes and genetic modeling.
Assoc. Prof. Dr. Yasemin CEYHAN is an accomplished academic in nursing, currently serving as an Associate Professor at Kırşehir Ahi Evran University's Faculty of Health Sciences, Department of Nursing. She has been a full-time faculty member since 2013, initially as a Research Assistant (2013-2020) and subsequently as a Doctoral Teaching Member (2020-present). She holds multiple administrative positions including Head of Department (2020-present), Faculty Council Member (2022-present), and Quality Committee Member (2024-present). Dr. CEYHAN completed her Bachelor's Degree in Nursing at Ahi Evran University (2007-2011), followed by a Master's Degree in Nursing at Erciyes University (2012-2015), and earned her Doctorate in Internal Medicine Nursing from Erciyes University (2015-2019). She has completed numerous specialized courses in statistical analysis, meta-analysis, and healthcare research methodology. Her research primarily focuses on Internal Medicine Nursing with particular expertise in Chronic Obstructive Pulmonary Disease (COPD) management, cultural competency in nursing practice, and patient self-management in chronic diseases. She has developed significant expertise in psychometric evaluation of nursing instruments and has contributed substantially to understanding the relationship between cultural sensitivity and nursing care effectiveness. Her work bridges nursing practice with psychological, cultural, and physiological aspects of patient care. Analysis of her publication record reveals a clear evolution from descriptive studies to sophisticated analytical research employing structural equation modeling and randomized controlled trials. Her recent work demonstrates increasing methodological rigor with a focus on mediation and moderation effects in complex patient care scenarios, particularly in COPD management where she examines intricate relationships between symptoms, psychological factors, and self-management behaviors. Poster Presentation 3rd Prize (2014) from Eskişehir Osmangazi University Dr. CEYHAN has successfully supervised multiple Master's theses and currently mentors additional graduate students. She has secured and led several significant research projects funded by TÜBA, TÜBİTAK, and university research funds, focusing on chronic disease management, cultural competency assessment tools, and COPD patient care. Her research portfolio demonstrates a strong commitment to evidence-based nursing practice and instrument development. As an active member of the Turkish Respiratory Research Association (since 2018) and the Turkish Nurses Association (since 2015), Dr. CEYHAN maintains a robust collaborative research network that spans multiple Turkish universities, particularly Erciyes University. Her work reflects a team-oriented research approach with numerous co-authored publications demonstrating interdisciplinary collaboration.
Dimitrios (Dimitris) Anastasiou is a Senior Group Leader at The Francis Crick Institute in London, UK, specializing in cancer metabolism research. Previously, he served as a Group Leader at the Medical Research Council National Institute for Medical Research (NIMR) starting in 2012 before transitioning to the Crick Institute in 2015. His research career includes postdoctoral work and an Instructor position at Beth Israel Deaconess Medical Center and the Department of Systems Biology, Harvard Medical School under Lewis Cantley, where he focused on metabolic reprogramming in cancer. University College London, UK - BSc Molecular Biology (2001) University of Basel, Basel, Switzerland - PhD in Biochemistry (2006) Anastasiou's research centers on understanding how cancer cells generate energy and utilize nutrients differently from normal cells. His laboratory conducts detailed analyses of metabolic pathways in cancer, investigating how tumor cells rewire their metabolism to support rapid growth and evade the body's defenses. His work spans biochemistry, proteomics, computational systems biology, human physiology, and tumor biology, with particular emphasis on identifying metabolic vulnerabilities that could be targeted for cancer therapy. His innovative approaches include developing chemical 'sensors' to monitor metabolic changes in cancer cells over time as tumors develop. Analysis of his recent publications reveals a consistent focus on metabolic regulation in cancer, particularly regarding glycolysis, hypoxia response, amino acid metabolism, and nucleotide biosynthesis. His work frequently examines enzyme regulation (particularly PKM2), metabolic adaptation to environmental stressors, and the intersection between metabolism and signaling pathways. A notable trend is his exploration of how metabolic enzymes function beyond their traditional roles, influencing cellular signaling and gene expression in cancer contexts. Anastasiou has made significant contributions to understanding metabolic reprogramming in cancer, particularly regarding pyruvate kinase M2 regulation, hypoxia responses, and nutrient utilization in tumor microenvironments. His work bridges basic biochemical mechanisms with potential therapeutic applications, focusing on identifying metabolic vulnerabilities in cancer cells that could be exploited for treatment. As a Senior Group Leader at the Crick Institute, Anastasiou leads a research group investigating how metabolism contributes to disease, particularly cancer. His laboratory utilizes a range of techniques including metabolomics, bioinformatics, structural biology, and high-throughput screening to study metabolic pathways. The group's work aims to identify fundamental differences between metabolic pathways in tumors and healthy tissue to discover new therapeutic targets against cancer.
Helen Byrne is a Professor of Applied Mathematics at the University of Oxford and a Tutorial Fellow at Keble College. Her academic roles include former Examiner for Final Honour School Mathematics, Associate Head of Department for Planning and Equality and Diversity, and Director of Equality and Diversity in the university’s MPLS Division. DPhil MSc BA/MA Her research focuses on developing mathematical and computational models to study biomedical systems, particularly solid tumours, wound healing, and tissue engineering. She aims to uncover mechanisms behind biological phenomena and derive novel mathematical insights from these models. Recent publications highlight her work in tumor-immune interactions, atherosclerosis, antibody dynamics, and radiation therapy, employing techniques like spatial modeling, agent-based simulations, and multiscale approaches. Her research bridges theoretical mathematics and practical biomedical challenges. 2019: Leah Edelstein-Keshet Prize (Senior Award), Society for Mathematical Biology 2020: Fellow of the Society for Mathematical Biology Helen Byrne has supervised numerous students and researchers, contributing to mathematical biology and biomedical modeling. Her teaching includes courses on multivariable calculus, applied partial differential equations, and advanced mathematical biology.
